Phospho-CDK2 (Thr160) Recombinant Antibody

$Western blot analysis of HeLa treated with nocodazole cell lysate. Using Phospho-CDK2 (Thr160) (bsm-62835R) monoclonal antibody at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.\r\n$

Western blot analysis of HeLa treated with nocodazole cell lysate. Using Phospho-CDK2 (Thr160) (bsm-62835R) monoclonal antibody at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.\r\n

Applications

Reactivity

Human

Overview
Catalog #	bsm-62835r
Product Name	Phospho-CDK2 (Thr160) Recombinant Antibody
Applications	WB
Reactivity	Human
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human CDK1 around the phosphorylation site of T161
Modification Site	Thr160
Clonality	Recombinant
Isotype	IgG
Concentration	Lot dependent
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	1017
Swiss Prot	P24941,P06493
Synonyms	CDC2; CDC28A; CDKN1; CDKN2; Cell division control protein 2 homolog; Cell division protein kinase 1; Cell division protein kinase 2; Cyclin-dependent kinase 1; Cyclin-dependent kinase 2; p33 protein kinase; p34 protein kinase; P34CDC2.
Background	Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis.
Application Dilution
WB	1:300-5000